טוען...
Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis
Rationale: Members of racial or ethnic minorities make up an appreciable proportion of patients with cystic fibrosis (CF) and have worse outcomes than non-Latino white individuals. Between 1,999 and 2014, the CF Foundation Patient Registry reported an increase in minorities from 5 to 8.2% for Latino...
שמור ב:
| הוצא לאור ב: | Ann Am Thorac Soc |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Thoracic Society
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122490/ https://ncbi.nlm.nih.gov/pubmed/27410177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201603-192BC |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|